Categories
Loading...
Categories
Alembic Pharmaceuticals Limited has announced a board meeting to address the loss of an equity share certificate for 41,550 shares linked to the deceased shareholder Prabhakar Rao Kulkarni. The company published a notice in the Business Standard, inviting claims from any persons regarding the shares, which must be submitted within 15 days to avoid the issuance of duplicate certificates. This move is aimed at maintaining shareholder confidence and ensuring proper management of equity documentation. Investors should view this as a focused effort to uphold transparency and secure shareholder interests, potentially fostering positive sentiment.